10 research outputs found
Acute Chemical Eye Injury and Limbal Stem Cell Deficiency - A Prospective Study in the United Kingdom
Measuring the benefit of 4 years of intravitreal ranibizumab treatment for neovascular age-related macular degeneration
Bevacizumab treatment for neovascular age-related macular degeneration in the setting of a clinic: “real life” long-term outcome
A Prospective Study of Treatment Patterns and 1-Year Outcome of Asian Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy
Cellular- and Acellular-Based Therapies: Skin Substitutes and Matrices
Recalcitrant wounds pose a challenge to the dermatologist. In recent years, many skin substitutes have been developed and are broadly classified as either acellular or cellular. These skin substitutes are to be used in concert with standard of care to provide the stalled wound with a scaffold and key elements such as cytokines, growth factors, and extracellular matrix substances. Skin substitutes help initiate and accelerate wound healing through granulation, cell migration, re-vascularization, and re-epithelialization. Wounds of varying etiologies have been shown to benefit from the multitude of acellular and cellular skin substitutes that are available. This chapter provides clinically relevant background and practical guidance about skin substitutes to allow dermatologists to effectively incorporate these powerful tools into their wound healing armamentarium